Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally
- PMID: 7297921
- PMCID: PMC1419868
- DOI: 10.1136/gut.22.9.728
Dose response inhibition in man of meal-stimulated gastric acid secretion by 15(R)-15-methyl prostaglandin E2, given orally
Abstract
15(R)-15-methyl prostaglandin E2 was given orally to healthy male volunteers. Thirty minutes later a 10% peptone meal was introduced into the stomach, and the acid response was measured by continuous intragastric titration with 0.5 N NaOH for the next two hours. The prostaglandin inhibited acid output in a dose dependent manner; the ED50 (dose inhibiting acid output by 50%) was as little as 10 micrograms per subject (or approximately 140 ng/kg). This compound is the most potent orally active inhibitor of gastric acid secretion in man that is known. It is likely that the antisecretory and cytoprotective properties shared by 15(R)-15-methyl prostaglandin E2 would be beneficial in the treatment of peptic ulcer and in preventing recurrences.
Similar articles
-
Gastric antisecretory activity of arbaprostil as affected by gastric pH.Dig Dis Sci. 1985 Jul;30(7):612-6. doi: 10.1007/BF01308408. Dig Dis Sci. 1985. PMID: 4006643
-
Effects of 15(R)-15-methyl prostaglandin E2 (arbaprostil) on gastric secretion and various gastric lesions induced in rats.Jpn J Pharmacol. 1986 Feb;40(2):329-37. doi: 10.1254/jjp.40.329. Jpn J Pharmacol. 1986. PMID: 3702150
-
Effect of orally administered 15(R)-15-methyl prostaglandin E2 and/or an anticholinergic drug on meal-induced gastric acid secretion and serum gastrin level in patients with duodenal ulcers.Scand J Gastroenterol. 1979;14(7):813-9. doi: 10.3109/00365527909181409. Scand J Gastroenterol. 1979. PMID: 395627 Clinical Trial.
-
[Gastric antisecretory effect of 15(R)-15 methyl PGE2 and 15(S)-15 methyl PGE2 in the rat].Nihon Shokakibyo Gakkai Zasshi. 1985 Jul;82(7):1684-92. Nihon Shokakibyo Gakkai Zasshi. 1985. PMID: 4079086 Japanese. No abstract available.
-
Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.Gastroenterology. 1976 Mar;70(3):359-70. Gastroenterology. 1976. PMID: 174967 Review.
Cited by
-
Isolation and characterization of the urinary metabolites of arbaprostil in the male dog after intravenous administration.Eur J Drug Metab Pharmacokinet. 1988 Apr-Jun;13(2):113-21. doi: 10.1007/BF03191312. Eur J Drug Metab Pharmacokinet. 1988. PMID: 3208790
-
Gastric antisecretory activity of arbaprostil as affected by gastric pH.Dig Dis Sci. 1985 Jul;30(7):612-6. doi: 10.1007/BF01308408. Dig Dis Sci. 1985. PMID: 4006643
-
Newer antisecretory agents for peptic ulcer.Drugs. 1983 Mar;25(3):315-30. doi: 10.2165/00003495-198325030-00003. Drugs. 1983. PMID: 6133734 Review. No abstract available.
-
Carbon Monoxide (CO) Released from Tricarbonyldichlororuthenium (II) Dimer (CORM-2) in Gastroprotection against Experimental Ethanol-Induced Gastric Damage.PLoS One. 2015 Oct 13;10(10):e0140493. doi: 10.1371/journal.pone.0140493. eCollection 2015. PLoS One. 2015. PMID: 26460608 Free PMC article.
-
Isolation and characterization of urinary metabolites of arbaprostil in the rat.Eur J Drug Metab Pharmacokinet. 1986 Jan-Mar;11(1):61-9. doi: 10.1007/BF03189776. Eur J Drug Metab Pharmacokinet. 1986. PMID: 3720796
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources